DNA Marker
The current role of 18F-FDOPA PET for neuroendocrine tumor imaging - ScienceDirect
![Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00259-021-05351-x/MediaObjects/259_2021_5351_Fig6_HTML.png "Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours | SpringerLink")
Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours | SpringerLink
Design, synthesis, and biological evaluation of small molecule PROTACs for potential anticancer effects | SpringerLink
Dolznig Lab | MedUni Vienna
Pathology Outlines - D2-40 (Podoplanin)
Uzlinový syndrom - Zdraví.euro.cz
LE PEN PERMANENT SETS — Marvy Uchida
Exposure to Bisphenol A Correlates with Early-Onset Prostate Cancer and Promotes Centrosome Amplification and Anchorage-Independent Growth In Vitro | PLOS ONE
Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer's disease | Scientific Reports
Evaluation of D-isomers of 4-borono-2-18F-fluoro-phenylalanine and O-11C-methyl-tyrosine as brain tumor imaging agents: a comparative PET study with their L-isomers in rat brain glioma | EJNMMI Research | Full Text
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology
![Frontiers | Usefulness of PET With [18F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment](https://www.frontiersin.org/files/Articles/528772/fneur-11-00754-HTML/image_m/fneur-11-00754-g001.jpg "Frontiers | Usefulness of PET With [18F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment")
Frontiers | Usefulness of PET With [18F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment
Effect of CD133 overexpression on bone metastasis in prostate cancer cell line LNCaP
Biomarkers in Alzheimer's disease
Acute effects of 4-EA-NBOMe, 3, 4-DCMP, LY-2183240 and AB-CHFUPYCA on the excitability of rat cortical primary cultured neurons | SpringerLink
Identification of cancer-type specific expression patterns for active aldehyde dehydrogenase (ALDH) isoforms in ALDEFLUOR assay
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology
Uzlinový syndrom - Zdraví.euro.cz
Immunopositivity for lymphatic endothelial marker D2-40 (podoplanin) in... | Download Scientific Diagram
![18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00259-020-04918-4/MediaObjects/259_2020_4918_Fig1_HTML.png "18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients | SpringerLink")
18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients | SpringerLink
The optimum marker for the detection of lymphatic vessels (Review)
ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome - ScienceDirect
